Lifespan Pharma Inc-Extend Lifespan Naturally-business plan pitch
•Transferir como PPT, PDF•
2 gostaram•2,088 visualizações
lifespan.pharma.inc@gmail.com is pitching this new patented healthspan optimization aid till may 30 to accredited investors in Saskatchewan 701-240-9411, 306-447-4944 box 33, beaubier, saskatchewan, S0C-0H0 Canada .. any comments??
![LIFESPAN PHARMA INC . ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],SWOT ANALYSIS Internal Strengths and Weaknesses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],External Opportunities and Threats ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],SUMMARY OF FINANCIAL RESULTS SCENARIO ANALYSIS CRITICAL VARIABLES BREAK EVEN ANALYSIS Crop Year 2009 2010 2011 2012 2013 Sales 31,604,160 39,062,742 48,281,549 59,675,994 73,759,529 COGS 4,835,450 6,430,069 7,924,682 9,777,136 12,066,739 Gross Margin 26,768,710 32,632,673 40,356,867 49,898,858 61,692,790 Expenses 602,424 615,347 633,807 657,971 672,406 Net Income Before Tax 26,166,286 32,017,326 39,723,060 49,240,887 61,020,384 Income Tax 8,010,049 9,503,698 11,219,572 13,193,539 16,374,004 Net Income After Tax 18,156,237 22,513,628 28,503,488 36,047,347 44,646,380 Net Cash Flow to Equity 16,465,525 22,149,619 28,037,937 35,460,750 43,910,336 Year 2014 2015 2016 2017 2018 Sales 91,166,778 112,682,137 139,275,122 172,144,051 212,770,047 COGS 14,896,391 18,397,910 22,724,973 28,072,317 34,685,222 Gross Margin 76,270,387 94,284,227 116,550,149 144,071,734 178,084,825 Expenses 692,406 718,660 734,756 756,799 784,966 Net Income Before Tax 75,577,808 93,565,567 115,815,392 143,314,934 177,299,858 Income Tax 20,304,508 25,161,203 31,168,656 38,593,532 47,769,462 Net Income After Tax 55,273,300 68,404,364 84,646,737 104,721,402 129,530,396 Net Cash Flow to Equity 54,352,446 67,259,364 83,224,094 102,954,911 127,342,724 Variable Base Case Break Even Worst Case Number of Sales 902,976 160,249 573,390 Price of Product 35 6.21 22.23 Product Testing 100,000 51,244,019 14,831,760 Bottling and Labeling 1,986,547 27,775,699 3,841,555 NPV 177,850,461 0 -17,713,283 IRR 893.40% 20% 0% Critical Value Base Case NPV=0 Allowable % Change Sales 902976 160246 -82.25% Price 35 6.21 -82.26% Product testing 100000 51,244,019 51144.02% Air time 200000 51,344,019 25572.01% Bottling and labelling 1986547 27,775,699 1298.19% L-carnosine 1986600 27,775,752 1298.16% Growth in selling prices 3.00% -181.40% -6146.67% Average days receivable 16 1,318 8137.50% Marketing expenses 471000 51,615,019 10858.60% Direct materials 5212537 31001689 494.75%](https://image.slidesharecdn.com/lifespan-pharma-inc-pitch-090325185348-phpapp02/85/Lifespan-Pharma-Inc-Extend-Lifespan-Naturally-business-plan-pitch-1-320.jpg)
Recomendados
Recomendados
Mais conteúdo relacionado
Mais procurados
Mais procurados (11)
Semelhante a Lifespan Pharma Inc-Extend Lifespan Naturally-business plan pitch
Semelhante a Lifespan Pharma Inc-Extend Lifespan Naturally-business plan pitch (20)
Mais de Morris Johnson
Mais de Morris Johnson (20)
Último
Último (20)
Lifespan Pharma Inc-Extend Lifespan Naturally-business plan pitch
- 2. Excepts from Patent number 2,636,594………. REGULATORY COMPLIANT METHOD TO GROW , HARVEST AND PRODUCE INDUSTRIAL MILLED HEMP SEED AND DERIVATIVE FUNCTIONAL PRODUCTS FOR HUMAN AND VETERINARY USE ABSTRACT: A Method to create a novel hempseed material embodying the chemistry of the whole hemp plant by utilizing a special harvesting method. The embodiments resulting from application of this method allow commercialization of hempseed in a broad range of end uses. Another embodiment preserves the integrity and stability of the hempseed. Yet another embodiment allows this material to be compliant with government regulatory laws and regulations in all the commercial applications of the novel hempseed material which are a direct result of and are dependant upon and require setting the harvester to intentionally break and crack the grain. FIELD OF THE INVENTION The following invention relates generally to the field of methods to allow regulatory compliance when growing, processing , distributing and selling Industrial Hemp Seed ( low delta 9 THC Cannabis Sativa ) As food, nutraceutical, food supplements, dietary supplements, natural health products, cosmetic or animal feed (or the equivalent class in any country this patent is registered in) . ……………………………………………………………………………………………………………………………………… . 8. Without this invention all the cited examples may result in commercial hempseed products which may be classified as pharmaceuticals or controlled substances. This invention allows commercialization of hempseed for a broad series of novel applications as foods, dietary supplements , nutraceuticals and cosmeceuticals and medicinal feedstocks. Current Lifespan Pharma Products: Hemp Capsules & Hemp for Horses